Trace and major elements in whole blood, serum, cerebrospinal fluid and urine of patients with Parkinson's disease

Journal of Neural Transmission

Volumn 111, Issue 8, 2004, Pages 1031-1040

  Forte, G ^a   Bocca, B ^a   Senofonte, O ^a   Petrucci, F ^a   Brusa, L ^a   Stanzione, P ^a   Zannino, S ^a   Violante, N ^a   Alimonti, A ^a,b   Sancesario, G ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Blood; Cerebrospinal fluid; Chemical elements; ICP AES; Oxidative damage; Parkinson's disease; Serum; SF ICP MS; Urine

Indexed keywords

ALUMINUM; CALCIUM; COPPER; IRON; MAGNESIUM; MANGANESE; SILICON; TRACE ELEMENT; ZINC;

ADULT; AGED; ALUMINUM BLOOD LEVEL; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; HUMAN; IRON BLOOD LEVEL; IRON URINE LEVEL; MAGNESIUM BLOOD LEVEL; MAGNESIUM URINE LEVEL; MALE; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; TRACE METAL BLOOD LEVEL; URINE LEVEL; ZINC BLOOD LEVEL;

EID: 3843052544     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-004-0124-0     Document Type: Article

References (35)

1. Birchall JD, Chappell JS (1988) The chemistry of aluminium and silicon in relation to Alzheimer's disease. Clin Chem 34: 265-267
2. Cabrera-Valdivia F, Jiménez-Jiménez FJ, Molina JA, Férnandez-Calle P, Vázquez A, Cañizares-Liébana F, Larumbe-Lobalde S, Ayuso-Peralta L, Rabasa M, Codoceo R (1994) Peripheral iron metabolism in patients with Parkinson's disease. J Neurol Sci 125: 82-86
3. Cesarone MR, Belcaro G, Carratelli M, Cornelli V, De Sanctis MT, Incandela L, Barsotti A, Terranova R, Nicolaides A (1999) A simple test to monitor oxidative stress. Int Angiol 18: 127-130
4. Daniel SE, Lees AJ (1993) Parkinson's disease society brain bank, London: overview and research. J Neural Transm 39: 165-172
5. Dexter DT, Wells FR, Lees AJ, Agid F, Agid Y, Jenner P, Marsden CD (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J Neurochem 52: 1830-1836
6. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975
7. Fahn S, Elton RL, UPDRS development committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, Golstein M (eds) Recent developments in Parkinson's disease. MacMillan Healthcare Information, NY, pp 153-163 and 293-304
8. Flaten TP (1987) Geographical associations between aluminium in drinking water and death rates with dementia, Parkinson's disease and amyotrophic lateral sclerosis in Norway. Trace Elem Med 4: 179-180
9. Forbes WF, Agwani N (1994) A suggested mechanism for aluminum biotoxicity. J Theor Biol 171: 207-214
10. Gazzaniga GC, Ferraro B, Camerlengo M, Casto L, Viscardi M, Mamoli A (1992) A case control study of CSF copper, iron and manganese in Parkinson's disease. Ital J Neurol Sci 13: 239-243
11. Glick JL (1990) Use of magnesium in the management of dementias. Med Sci Res 18: 831-833
12. Halliwell B, Gutteridge JMC (1985) Oxygen-radicals and the nervous system. Trends Neurosci 8: 22-26
13. Halliwell B, Gutteridge JMC (1988) Iron as a biological pro-oxidant. ISI Atlas Sci Biochem 1: 48-52
14. Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y (1991) Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem 56: 446-451
15. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-442
16. Iregren A, Sjögren B, Gustafsson K, Hagman N, Nylén L, Frech W, Andersson M, Ljunggren KG, Wennberg A (2001) Effects on the nervous system in different groups of workers exposed to aluminium. Occup Environ Med 58: 453-460
17. Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MBH (1990) Brain iron and ferritin in Parkinson's and Alzheimer's diseases. J Neural Transm [PD Sect] 2: 327-340
18. Jiménez-Jiménez FJ, Fernandez-Calle P, Martinez-Vanaclocha M, Herrero E, Molina JA, Vasquez A, Codoceo R (1992) Serum levels of zinc and copper in patients with Parkinson's disease. J Neurol Sci 112: 30-33
19. Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Arrieta FJ, Jorge-Santamaría A, Cabrera-Valdivia F, Ayuso-Peralta L, Rabasa M, Vázquez A, García E, Martínez-Para MC (1995) Serum and urinary manganese levels in patients with Parkinson's disease. Acta Neurol Scand 91: 317-320
20. Jiménez-Jiménez FJ, Molina JA, Aguilar MV, Meseguer I, Mateos-Vega CJ, González-Muñoz MJ, de Bustos F, Martínez-Salio A, Ortí-Pareja M, Zurdo M, Martínez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease. J Neural Transm 105: 497-505
21. Kienzl E, Jellinger K, Stachelberger H, Linert W (1999) Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease. Life Sci 65: 1973-1976
22. McLachlan D (1995) Aluminium and the risk for Alzheimer's disease. Environmetrics 6: 233-275
23. Montgomery EB Jr (1995) Heavy metals and the etiology of Parkinson's disease and other movement disorders. Toxicology 97: 3-9
24. Pall HS, William AC, Blake DR, Lunec J, Gutteridge JM, Hall M, Taylor A (1987) Raised cerebrospinal fluid copper concentration in Parkinson's disease. Lancet ii: 238-241
25. Pamphlett R, McQuilty R, Zarkos K (2001) Blood levels of toxic and essential metals in motor neuron disease. Neurotoxicology 22: 401-410
26. Pan BY, Cheng QL, He ZX, Su CC (1997) Transition metals in serum and CSF of patients with Parkinson's disease. XIIth International Symposium on Parkinson's disease, London, March 23-26. Mov Disord 12[Suppl 1]: 33 (P125)
27. Provan SD, Yorkel RA (1990) Reduced intestinal calcium and dietary calcium intake, increased aluminium absorption and tissue concentration in the rat. Biol Trace Elem Res 23: 119-131
28. Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515-520
29. Saggu H, Cooksey D, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53: 692-697
30. Sayre ML, Perry G, Atwood SC, Smith AM (2000) The role of metals in neurodegenerative diseases. Cell Mol Biol 46(4): 731-741
31. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer's disease. Neurology 59: 1153-1161
32. Tórsdóttir G, Kristinsson J, Sveinbjörnsdóttir S, Snaedal J, Jóhannesson T (1999) Copper, ceruloplasmin, superoxide dismutase and iron parameters in Parkinson's disease. Pharmacol Toxicol 85: 239-243
33. Verity MA (1999) Manganese neurotoxicity: a mechanistic hypothesis. Neurotoxicology 20: 489-498
34. Witholt R, Gwiazda RH, Smith DR (2000) The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism. Neurotoxicol Teratol 22: 851-861
35. Yasui M, Kihira T, Ota K (1992) Calcium, magnesium and aluminium concentrations in Parkinson's disease. Neurotoxicology 13: 593-600